ADV SCI 润色咨询

Advanced Science

出版年份:暂无数据 年文章数:3863 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2024-03-04 759706283 来自德克萨斯

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:生命科学;神经调控
    经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2024-01-23 1522336 来自重庆

    请问with editor大概多久能有消息? 已经一周多了

    13

    展开13条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    昨天 osmataku 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2023-08-26 Ozeaaan 来自江苏省

    偏重的研究方向:医学;神经免疫
    经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。

    19

    展开19条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2024-03-22 122aa381m91(暂无昵称) 来自北京

    审稿速度:12.0 | 投稿命中率:25.0
    偏重的研究方向:基础医学
    经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2024-03-06 ms1000001659923753 来自密苏里

    偏重的研究方向:临床医学
    经验分享:这个和cell reports比怎么样

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2023-09-05 759706283 来自陕西省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:生命科学;神经调控
    经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2024-02-23 小涛comeon 来自陕西省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:牙周再生;生物材料
    经验分享:2023.12.07 投稿;
    2023.12.30 状态变成under review;
    2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;
    2024.2.02文章返修;
    2024.2.02状态变成under review;
    2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;
    2024.2.16上午文章返修;
    2024.2.16下午文章接收!

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2019-08-25 ms8592312893450551

    审稿速度:2.0
    经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2191067, encodeId=6d3b219106e04, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:想问问大家,2修提交5天了还没到编辑手上,显示提交状态,这是啥情况啊,2修也这么慢吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Mon Mar 04 23:33:22 CST 2024, time=2024-03-04, status=1, ipAttribution=德克萨斯), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息? 已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2195634, encodeId=36792195634ff, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:advanced science 材料学杂志,也收生物医学文章。15分的影响因子在材料领域只算起步价,不过15分在生物医学领域还是不错了。可以考虑错位竞争,生物医学文章投这个杂志性价比超高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:35:18 CST 2024, time=昨天, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向:医学;神经免疫<br>经验分享:大家最近投这个的进度怎么样呀?我们最近投的一篇2周了还在manuscript submitted,很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0<br>偏重的研究方向:基础医学<br>经验分享:感觉有必要分享下经验。去年投稿AS,一审超过2个月,给了修改意见,3个审稿人,补实验修回后,二审很快,差不多两周,2个审稿人同意发表,1个审稿人说了一大堆不满意的,结果编辑给了拒稿重投的决定。这种情况以往经验来看,结果不会太好,但发现那个审稿人不熟悉这个领域,意见在逻辑上有漏洞。因此又补了点实验,决定重投。经过2个月Under Review, 突然收到来信,直接接收,一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向:临床医学<br>经验分享:这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2156206, encodeId=b2892156206fd, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:生命科学;神经调控<br>经验分享:8月10日投稿,8月31with editor, 9月1日Under review。。。希望顺利哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=925a4886082, createdName=759706283, createdTime=Tue Sep 05 14:29:53 CST 2023, time=2023-09-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188948, encodeId=c208218894810, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:牙周再生;生物材料<br>经验分享:2023.12.07 投稿;<br>2023.12.30 状态变成under review;<br>2024.1.12收到审稿意见,一接收,两小修,编辑给的大修;<br>2024.2.02文章返修;<br>2024.2.02状态变成under review;<br>2024.2.12收到审稿意见,所有审稿人都同意接收,编辑让修改一下材料方法,给的小修;<br>2024.2.16上午文章返修;<br>2024.2.16下午文章接收!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lUW1nNyW62fNj1bdunPLr4BtDXcaFjx3KhGbzkuqUEwibYcMadGuA6q7PeG25dkUsZtFto2O07dl3YF1AMU22VA/132, createdBy=8c1b2456395, createdName=小涛comeon, createdTime=Fri Feb 23 17:24:59 CST 2024, time=2024-02-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=853383, encodeId=20638533834a, content=审稿速度:2.0<br>经验分享:6.07投稿,8.09得到小修意见,8.17返回修改稿,当天接受~~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11cc5414110, createdName=ms8592312893450551, createdTime=Sun Aug 25 12:41:43 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944103, encodeId=af0a9441032f, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0<br>经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。<br>真的没失望,审稿速度非常块,从投到接收,刚好一个月。<br>2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffc95237609, createdName=chemp_99634330, createdTime=Sun Feb 28 10:49:08 CST 2021, time=2021-02-28, status=1, ipAttribution=)]
    2021-02-28 chemp_99634330

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:5000.0
    经验分享:稿子本来是打算投AFM的,在网上看AFM比较慢,不想太纠结,就选投IF差不多的AS了。
    真的没失望,审稿速度非常块,从投到接收,刚好一个月。
    2个审稿人,审稿意见共13条,意见很专业,其中有几条意见比较刁钻,我一个星期基本上没有睡觉,补了3个实验,写了十几页回复意见,提交后3天就接受。非常高效率、高质量的一本期刊。但是广告方面做的太差了,其他新期刊都是轮番在公众号上宣传,还开各种网络学术会议宣传,但是这本期刊的宣传确实有些落伍了。

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分